[ET Net News Agency, 2 September 2022] CKLIFE SCIENCES (00775) rose 17.39% to HK$0.81,
breaking above the 250-D SMA of HK$0.706.
It hits an intra-day high of HK$0.83, hitting an 1-month high, and an intra-day low of
HK$0.68. The total shares traded was 49.57 million, with a value of HK$37.76m. The active
buy/sell ratio is 69:31, with net buying turnover of HK$13.46m. CHINA INNOVATION MARKET
SER accounts for greatest net responsive buying turnover of HK$3.15m, with volume weighted
average price of HK$0.757. FUTU SEC INT'L accounts for greatest net responsive selling
turnover of HK$1.47m, with volume weighted average price of HK$0.776.
The Hang Seng Index now fell 101 points, or 0.52% to 19,496; the Hang Seng China
Enterprises Index now fell 46 points, or 0.68% to 6,695; the Hang Seng TECH Index now fell
33 points, or 0.81% to 4,170; with an overall turnover of HK$44.31b.
The SSE Composite Index now rose 8 points, or 0.28% to 3,193, with an overall turnover
of RMB193.47b.
The SZSE Component Index now rose 27 points, or 0.23% to 11,739, with an overall
turnover of RMB109.87b.
Basic Information
=================
----------------------------------
Nominal 0.810 % Chg +17.39%
High 0.830 Low 0.680
Shares Tr 49.57m Turnover 37.76m
10-D SMA 0.702 %H.V 23.696
20-D SMA 0.726 VWAP 0.762
50-D SMA 0.765 RSI14 64.819
----------------------------------
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is
69:31, with net buying turnover of HK$13.46m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CKLIFE SCIENCES (00775) 0.81 +17.39
TRAD CHI MED (00570) 3.43 -0.29
CSPC PHARMA (01093) 7.93 -1.37
SINO BIOPHARM (01177) 4.06 -1.22
SIMCERE PHARMA (02096) 8.60 +3.49
FOSUN PHARMA (02196) 25.10 -0.79
WUXI APPTEC (02359) 84.75 -1.80
SH PHARMA (02607) 11.56 -0.86
CHINARES PHARMA (03320) 5.59 +0.90
HANSOH PHARMA (03692) 14.26 -4.68
-----------------------------------------------
(ed)